Back

Old and new anticoagulants in acute pulmonary embolism - Conclusion.

2 March 2019 (12:15 - 12:30)
Organised by:
Congress Presentation Part of: Old and new anticoagulants in acute pulmonary embolism: looking for the best? Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure ACVC Premium Access Acute Cardiovascular Care 2019

About the speaker

Photo
Doctor Maddalena Lettino

IRCCS San Gerardo of Tintori Foundation, Monza (Italy)

5 More presentations in this session

Presentation thumbnail
Positioning of the topic - Old and new anticoagulants in acute pulmonary embolism
Professor F. Verheugt (Amsterdam, NL)
Slides Video
Presentation thumbnail
A DOAC is always indicated in the acute phase of PE - PRO.
Professor F. Andreotti (Rome, IT)
Presentation thumbnail
A DOAC is always recommended in the acute phase of PE - CONTRA.
Professor F. Verheugt (Amsterdam, NL)
Slides Video
Presentation thumbnail
A DOAC is always indicated in the acute phase of PE - Rebuttal.
Professor F. Verheugt (Amsterdam, NL) Professor F. Andreotti (Rome, IT)
Presentation thumbnail
Old and new anticoagulants in acute pulmonary embolism - Moderated discussion.
Professor F. Verheugt (Amsterdam, NL)

Access the full session

Session thumbnail
Old and new anticoagulants in acute pulmonary embolism: looking for the best?

The Event

Event poster

Acute Cardiovascular Care 2019

2 March 2019 12:15 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources